Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study
Purpose To compare results in patients treated with additional radiofrequency ablation (RFA) after clinical evaluation or vital volume (Va) increase. Methods Forty patients with 42 benign thyroid nodules who underwent additional RFA were evaluated in this retrospective study. According to the differ...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | International Journal of Hyperthermia |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/02656736.2020.1778197 |
id |
doaj-4081e41f1f1b440e98c8b10fab423381 |
---|---|
record_format |
Article |
spelling |
doaj-4081e41f1f1b440e98c8b10fab4233812021-08-09T15:50:02ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572020-01-0137177778510.1080/02656736.2020.17781971778197Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective studyLin Yan0Yukun Luo1Mingbo Zhang2Jing Xiao3Department of Ultrasound, First Medical Center, Chinese PLA General HospitalDepartment of Ultrasound, First Medical Center, Chinese PLA General HospitalDepartment of Ultrasound, First Medical Center, Chinese PLA General HospitalDepartment of Ultrasound, First Medical Center, Chinese PLA General HospitalPurpose To compare results in patients treated with additional radiofrequency ablation (RFA) after clinical evaluation or vital volume (Va) increase. Methods Forty patients with 42 benign thyroid nodules who underwent additional RFA were evaluated in this retrospective study. According to the different indication for additional RFA, 18 patients were divided into Vv increase group (V group) and 22 into clinical evaluation group (C group). Patients were followed up at 1, 3, 6, 12 months and every 12 months thereafter by conventional ultrasound (US), contrast-enhancement ultrasound (CEUS) and clinical evaluation. Volume, volume reduction rate (VRR), symptom score and cosmetic score were evaluated before treatment and each ablation. Results After the first RFA, there were no statistically differences between two groups in volume, VRR, cosmetic and symptom scores. Compared with the first RFA, volume of all the patients after additional RFA decreased significantly (p < 0.001). In additional RFA, during a mean follow-up time of 10.15 ± 9.17 months, volume in V group was significantly smaller than in C group (2.84 ± 5.43 ml Vs 7.39 ± 13.01 ml, p = 0.046). VRR in V group was significantly larger than in C group (90.18 ± 12.74% Vs 75.66 ± 26.47%, p = 0.007) with significant improvement of cosmetic and symptom scores (p = 0.047; p = 0.030). No complications occurred after each session ablation. Conclusion Vv increase was a more reliable indicator for additional RFA than clinical evaluation. Additional RFA performed after Vv increase was more effective with respect to volume reduction and improvement of clinical outcomes. Therefore, Vv increase should be set as an indication for additional RFA.http://dx.doi.org/10.1080/02656736.2020.1778197radiofrequency ablationthyroid nodulesadditionalultrasoundvital volumecontrast-enhanced ultrasound |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lin Yan Yukun Luo Mingbo Zhang Jing Xiao |
spellingShingle |
Lin Yan Yukun Luo Mingbo Zhang Jing Xiao Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study International Journal of Hyperthermia radiofrequency ablation thyroid nodules additional ultrasound vital volume contrast-enhanced ultrasound |
author_facet |
Lin Yan Yukun Luo Mingbo Zhang Jing Xiao |
author_sort |
Lin Yan |
title |
Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study |
title_short |
Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study |
title_full |
Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study |
title_fullStr |
Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study |
title_full_unstemmed |
Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study |
title_sort |
vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study |
publisher |
Taylor & Francis Group |
series |
International Journal of Hyperthermia |
issn |
0265-6736 1464-5157 |
publishDate |
2020-01-01 |
description |
Purpose To compare results in patients treated with additional radiofrequency ablation (RFA) after clinical evaluation or vital volume (Va) increase. Methods Forty patients with 42 benign thyroid nodules who underwent additional RFA were evaluated in this retrospective study. According to the different indication for additional RFA, 18 patients were divided into Vv increase group (V group) and 22 into clinical evaluation group (C group). Patients were followed up at 1, 3, 6, 12 months and every 12 months thereafter by conventional ultrasound (US), contrast-enhancement ultrasound (CEUS) and clinical evaluation. Volume, volume reduction rate (VRR), symptom score and cosmetic score were evaluated before treatment and each ablation. Results After the first RFA, there were no statistically differences between two groups in volume, VRR, cosmetic and symptom scores. Compared with the first RFA, volume of all the patients after additional RFA decreased significantly (p < 0.001). In additional RFA, during a mean follow-up time of 10.15 ± 9.17 months, volume in V group was significantly smaller than in C group (2.84 ± 5.43 ml Vs 7.39 ± 13.01 ml, p = 0.046). VRR in V group was significantly larger than in C group (90.18 ± 12.74% Vs 75.66 ± 26.47%, p = 0.007) with significant improvement of cosmetic and symptom scores (p = 0.047; p = 0.030). No complications occurred after each session ablation. Conclusion Vv increase was a more reliable indicator for additional RFA than clinical evaluation. Additional RFA performed after Vv increase was more effective with respect to volume reduction and improvement of clinical outcomes. Therefore, Vv increase should be set as an indication for additional RFA. |
topic |
radiofrequency ablation thyroid nodules additional ultrasound vital volume contrast-enhanced ultrasound |
url |
http://dx.doi.org/10.1080/02656736.2020.1778197 |
work_keys_str_mv |
AT linyan vitalvolumeincreaseversusclinicalevaluationastheindicationofadditionalradiofrequencyablationforbenignthyroidnoduleasinglecenterretrospectivestudy AT yukunluo vitalvolumeincreaseversusclinicalevaluationastheindicationofadditionalradiofrequencyablationforbenignthyroidnoduleasinglecenterretrospectivestudy AT mingbozhang vitalvolumeincreaseversusclinicalevaluationastheindicationofadditionalradiofrequencyablationforbenignthyroidnoduleasinglecenterretrospectivestudy AT jingxiao vitalvolumeincreaseversusclinicalevaluationastheindicationofadditionalradiofrequencyablationforbenignthyroidnoduleasinglecenterretrospectivestudy |
_version_ |
1721213868331499520 |